{"id":"927bfe6f-29c5-4b26-a5e5-890b14f93377","kind":"news","code":"927bfe6f-29c5-4b26-a5e5-890b14f93377","name":"Yaowumuchang raises USD 55 million in Series D financing","nameBasis":"translated-title","summary":"On 2026-07-13, according to Xiniu Data, Yaowumuchang completed Series D financing, raising USD 55 million. Investors were lead investor Pudong Venture Capital Group, participating investor Zhikai Capital, participating investor Shenzhen City Luohudonghairuizhi Pharmaceutical Industrial Investment Partnership (Limited Partnership), participating investor Keyuanzhiyao, participating investor Baiaoweida, participating investor YD Capital, participating investor Jiashanguotou, participating investor Detong Capital, participating investor Weidu Capital, participating investor Biometas. The company is a novel drug developer.","description":"","country":null,"category":null,"originalName":"药物牧场完成D轮融资，金额5500万美元","eventDate":"2026-07-13T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T06:08:29.324Z","englishUpdatedAt":"2026-10-20T18:31:05.607Z","reviewedAt":"2026-10-20T18:31:05.607Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"a068d88804f6f211ea1443fe67163e450adefaaa3ff8e4706b56f737498056a1","companyId":"1390f593-b8fb-473f-b576-ab3894e8ff7c","foundedYear":null,"logoUrl":null,"originalText":"2026年7月13日，据烯牛数据报道，药物牧场完成D轮融资，金额5500万美元。投资方为浦东创投集团领投，致凯资本、深圳市罗湖东海睿智医药产业投资合伙企业（有限合伙）、科源制药、百奥维达、YD Capital、嘉善国投、德同资本、苇渡资本、Biometas跟投。该公司为原创新药研发商。","sources":[],"related":[{"id":"26d04e83-2c6c-438e-a12c-cc1591f7abb6","kind":"institutions","code":"UB-I8586","name":"Baiaoweida","nameBasis":"transliterated","summary":"Baiaoweida, an early-stage venture capital firm focused on healthcare.","description":"Baiaoweida, an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"百奥维达","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:26:22.204Z","englishUpdatedAt":"2026-10-15T17:35:38.723Z","reviewedAt":"2026-10-15T17:35:38.723Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"271d45debada3a755ba6be10d576ba9e11eef64b8ed0a8e7cbc15ef2c1461df7","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/baiaoweida"},{"id":"077714d0-13f0-4309-81ce-e313c55ffadb","kind":"institutions","code":"UB-I8629","name":"Biometas","nameBasis":"original-brand","summary":"Biometas, an early-stage venture capital firm focused on healthcare.","description":"Biometas, an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"Biometas","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:22.315Z","englishUpdatedAt":"2026-10-15T17:35:38.559Z","reviewedAt":"2026-10-15T17:35:38.559Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3f1e20b080ee041eb1cfb6c1511bb028f579e49b0ff48ad9d9821c92986c98ce","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/biometas"},{"id":"20065267-94fd-4042-8686-67aece40d072","kind":"institutions","code":"UB-I5860","name":"Detong Capital","nameBasis":"transliterated","summary":"Detong Capital is a Chinese private equity firm, specializing in equity investment in growth-stage and mature companies.","description":"Detong Capital is a Chinese private equity firm, specializing in equity investment in growth-stage and mature companies.","country":null,"category":null,"originalName":"德同资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:25.047Z","englishUpdatedAt":"2026-10-15T18:26:24.745Z","reviewedAt":"2026-10-15T18:26:24.745Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7bac143ef02fce25b4a90e4e3fc1991333103f9c473b3b2066bfe94e83dd2794","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/detong-capital"},{"id":"98dd05f3-4837-4ef5-a70b-e0f16e38c5ce","kind":"institutions","code":"UB-I8720","name":"Jiashanguotou","nameBasis":"transliterated","summary":"Jiashanguotou, an investment guidance fund backed by government or state-owned capital.","description":"Jiashanguotou, an investment guidance fund backed by government or state-owned capital.","country":null,"category":null,"originalName":"嘉善国投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:23.283Z","englishUpdatedAt":"2026-10-15T17:35:39.454Z","reviewedAt":"2026-10-15T17:35:39.454Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"061da645e056598d4d989e105e002757dd3506dad21eb889d2ce17d186d28951","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/jiashanguotou"},{"id":"6d5eedff-8291-4b23-89ee-ed121b29bf20","kind":"institutions","code":"UB-I8707","name":"Keyuanzhiyao","nameBasis":"transliterated","summary":"Keyuanzhiyao, an investment entity undertaking strategic investments.","description":"Keyuanzhiyao, an investment entity undertaking strategic investments.","country":null,"category":null,"originalName":"科源制药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:23.045Z","englishUpdatedAt":"2026-10-15T17:35:39.177Z","reviewedAt":"2026-10-15T17:35:39.177Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"504ceca184451bf1ca12077bfd40fcd5931a4d1be4a81a4c050ce23490915ed0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/keyuanzhiyao"},{"id":"03efbee3-8a61-49c4-a450-f285004a3ebd","kind":"institutions","code":"UB-I3789","name":"Pudong Venture Capital Group","nameBasis":"transliterated","summary":"Shanghai Pudong state-capital-backed venture capital group.","description":"Shanghai Pudong state-capital-backed venture capital group.","country":null,"category":null,"originalName":"浦东创投集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:10:25.334Z","englishUpdatedAt":"2026-10-15T20:13:55.766Z","reviewedAt":"2026-10-15T20:13:55.766Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"b73c37e07c192fb91af6875df7120ddffc5ac0072cf48e34bbeb695ba06ef6e0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/pudong-venture-capital-group"},{"id":"6bbac965-14cf-4a3c-8a81-fb0eee3c3ebd","kind":"institutions","code":"UB-I8699","name":"Shenzhen City Luohudonghairuizhi Pharmaceutical Industrial Investment Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Shenzhen Luohu Donghai Ruizhi Pharmaceutical Industry Investment Partnership (Limited Partnership), an industry investment fund focused on healthcare.","description":"Shenzhen Luohu Donghai Ruizhi Pharmaceutical Industry Investment Partnership (Limited Partnership), an industry investment fund focused on healthcare.","country":null,"category":null,"originalName":"深圳市罗湖东海睿智医药产业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:23.012Z","englishUpdatedAt":"2026-10-15T21:41:49.066Z","reviewedAt":"2026-10-15T21:41:49.066Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"709689a9e468b5471acd520324fa4dad129b448979b09cfaff9e777da251cbbb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/shenzhen-city-luohudonghairuizhi-pharmaceutical-industrial-investment-partnership-limited-partnership"},{"id":"5468d929-a9b0-4729-8eae-d576f38dfb2c","kind":"institutions","code":"UB-I8746","name":"Weidu Capital","nameBasis":"transliterated","summary":"Weidu Capital, an early-stage venture capital firm focused on healthcare.","description":"Weidu Capital, an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"苇渡资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:23.531Z","englishUpdatedAt":"2026-10-15T17:35:39.020Z","reviewedAt":"2026-10-15T17:35:39.020Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ca518c556ea46d1cfac2d2835c34c5322bbecac0174a127060509094fb969e3e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/weidu-capital"},{"id":"c53986b7-1ec6-42b6-beb1-50b3a617e8fd","kind":"institutions","code":"UB-I8594","name":"YD Capital","nameBasis":"original-brand","summary":"YD Capital, an early-stage venture capital firm focused on healthcare.","description":"YD Capital, an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"YD Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:26:22.240Z","englishUpdatedAt":"2026-10-15T17:35:39.711Z","reviewedAt":"2026-10-15T17:35:39.711Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0136f01f70a4441e097f535c93c1aa42c8cd00a42bd42ab593d2dfc7b4324e9d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/yd-capital"},{"id":"1390f593-b8fb-473f-b576-ab3894e8ff7c","kind":"companies","code":"UB-C10541","name":"Yaowumuchang","nameBasis":"transliterated","summary":"Novel drug developer.","description":"Novel drug developer.","country":"China","category":null,"originalName":"药物牧场","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:21:35.141Z","reviewedAt":"2026-10-20T18:21:35.141Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"1461a2209879bbd56749d4d5290dbe67a97266f2785c43ef752a475d147bbc3d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C10541"},{"id":"02af5952-b4e6-42b1-a35a-51306bb0c485","kind":"institutions","code":"UB-I8685","name":"Zhikai Capital","nameBasis":"transliterated","summary":"Zhikai Capital, an early-stage venture capital firm focused on healthcare.","description":"Zhikai Capital, an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"致凯资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:22.903Z","englishUpdatedAt":"2026-10-15T17:35:38.529Z","reviewedAt":"2026-10-15T17:35:38.529Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fcbeffc082e8d5171e1f85ded8ed4a5568777c79f043a099ff87a61bf67dd9e0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/zhikai-capital"}],"path":"/news/927bfe6f-29c5-4b26-a5e5-890b14f93377","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Yaowumuchang","path":"/companies/UB-C10541"}},"canonical":"https://uniquebase.ai/news/927bfe6f-29c5-4b26-a5e5-890b14f93377"}